Výsledky vyhledávání - "M.T. Bastiaens"

Akademický článek

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice

Autor: L.S. van der Schoot, J.J. Janssen, M.T. Bastiaens, A. de Boer-Brand, C. Christiaansen-Smit, D.N.H. Enomoto, R. Hovingh, R.A. Tupker, M.M.B. Seyger, L.M. Verhoef, J.M.P.A. van den Reek, E.M.G.J. de Jong

Publikováno v: Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)

Background Dose reduction (DR) of adalimumab, etanercept and ustekinumab has proven to be (cost-)effective in psoriasis patients with low disease activity. Further implementation is needed to establish application of DR for eligible patients. Objecti

Externí odkaz: https://doaj.org/article/cb7f4104cec94680ad8c747e5d548f2f

Zobrazit plný text záznamu

Plný text ve formátu HTML

Factors influencing current low‐value follow‐up care after basal cell carcinoma and suggested strategies for de‐adoption: a qualitative study

Autor: M.T. Bastiaens, M. Lugtenberg, Marlies Wakkee, S. van Egmond, A. van Rengen, Tamar Nijsten

Publikováno v: British Journal of Dermatology, 180(6), 1420-1429. Wiley-Blackwell Publishing Ltd
The British Journal of Dermatology

Summary Background Providing follow‐up to patients with low‐risk basal cell carcinoma (BCC) can be considered as low‐value care. However, dermatologists still provide substantial follow‐up care to this patient group, for reasons not well unde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8574f56fb201fc0f6c07dafa68567862
https://doi.org/10.1111/bjd.17594

Zobrazit plný text záznamu

Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study

Autor: M. Lugtenberg, M.T. Bastiaens, M. Droger, S. van Egmond, Tamar Nijsten, K.P. de Roos, Marlies Wakkee, A. van Rengen

Publikováno v: British Journal of Dermatology, 180(1), 122-129. Wiley-Blackwell Publishing Ltd

Background: Despite the high and rising incidence rate of keratinocyte cancer (KC) and the importance of incorporating patient values into evidence-based care, few studies have focused on the perspectives of patients with KC. Objectives: To identify

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::404087629f388ec243c8eb192a1cd72a
https://pure.eur.nl/en/publications/0f906fcf-8126-44ed-ac9c-937d82fae6b6

Zobrazit plný text záznamu

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care?

Autor: Sven van Egmond, M.T. Bastiaens, Esther de Vries, Danielle I.M. Kuijpers, Klara Mosterd, Loes M. Hollestein, Marlies Wakkee, Tamar Nijsten, Esther W. de Bekker-Grob, Kees-Peter de Roos, Ewout W. Steyerberg

Publikováno v: PLoS ONE, Vol 16, Iss 3, p e0249298 (2021)
PLoS ONE, 16(3). PUBLIC LIBRARY SCIENCE
PLOS ONE, 16(3):e0249298. Public Library of Science
PLoS ONE, 16(3 March):e0249298. Public Library of Science
PLoS ONE

Background Follow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this ‘low-value’ care, it is important to obtain insights int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ce41b4f2eef2e0a58009ebfac4fdf5
http://www.scopus.com/inward/record.url?scp=85103505248&partnerID=8YFLogxK

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání